607 Results

People

  1. Aghajanian
    Aghajanian
  2. Abu-Rustum
    Abu-Rustum
  3. Iasonos
    Iasonos
  4. Spriggs
    Spriggs
  5. O'Cearbhaill
    O'Cearbhaill
  6. Hensley
    Hensley
  7. Makker
    Makker
  8. Zhou
    Zhou
  9. Grisham
    Grisham
  10. Konner
    Konner

Groups

  1. Department of Medicine (607)
  2. GDMT, Medicine (607)
  3. Gynecologic Medicine Service (607)
  4. Gynecology Disease Management Team (607)
  5. Solid Tumor Oncology Division (607)
  6. Surgery (226)
  7. GDMT, Surgery (193)
  8. Epidemiology and Biostatistics (163)
  9. Biostatistics Service (143)
  10. GDMT, Pathology and Laboratory Medicine (137)
  1. "Carol Aghajanian"
Formats
  1. Journal Article (318)
  2. Meeting Abstract (284)
  3. Review (2)
  4. Book Section (1)
  5. Correspondence (1)
  6. Editorial (1)
Groups
  1. Department of Medicine (607)
  2. GDMT, Medicine (607)
  3. Gynecologic Medicine Service (607)
  4. Gynecology Disease Management Team (607)
  5. Solid Tumor Oncology Division (607)
  6. Surgery (226)

More Groups

People
  1. Carol Aghajanian (607)
  2. Paul Sabbatini (125)
  3. Nadeem Abu-Rustum (123)
  4. Alexia Iasonos (114)
  5. David Spriggs (105)
  6. Roisin O'Cearbhaill (99)

More People

Years
  1. 2025 (16)
  2. 2024 (38)
  3. 2023 (42)
  4. 2022 (45)
  5. 2021 (35)
  6. 2020 (61)

More Years

Publications
  1. Gynecologic Oncology (198)
  2. Journal of Clinical Oncology (149)
  3. International Journal of Gynecological Cancer (57)
  4. Clinical Cancer Research (29)
  5. Annals of Oncology (28)
  6. Cancer (15)

More Publications

Publishers
  1. Elsevier Inc. (215)
  2. American Society of Clinical Oncology (155)
  3. Lippincott Williams & Wilkins (59)
  4. American Association for Cancer Research (53)
  5. Oxford University Press (30)
  6. Wiley Blackwell (17)

More Publishers

Results (607)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: Overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial
    Journal Article

    Eskander, R. N.; Sill, M. W.; Beffa, L.; Moore, R. G.; Hope, J. M.; Musa, F. B.; Mannel, R. S.; Shahin, M. S.; Cantuaria, G. H.; Girda, E.; more...
    Nature Medicine (2025)

    Fulltext@MSK | Save
  • Prognostic significance of estrogen receptor expression and estrogen signaling in endometrial carcinomas of no specific molecular profile: A comprehensive molecular and pathologic analysis
    Journal Article

    Lam, C.; Zhou, Q.; Aghajanian, C.; Abu-Rustum, N. R.; Mueller, J. J.; Ellenson, L. H.; Green, A. K.; Weigelt, B.; Jungbluth, A. A.; Momeni-Boroujeni, A.
    Gynecologic Oncology (2025)

    Fulltext@MSK | Save
  • TROP2 expression and therapeutic targeting in uterine carcinosarcoma
    Journal Article

    Moufarrij, S.; Dopeso, H.; Brown, D. N.; Green, H.; Gill, K.; Tengelin, J.; Brodeur, M. N.; Zammarrelli, W. A. 3rd; Varice, N.; Wu, M.; more...
    Gynecologic Oncology (2025)

    Fulltext@MSK | Save
  • Impact of adding the immune checkpoint inhibitor atezolizumab to first-line chemotherapy on progression-free survival in poor-prognosis ovarian cancer: A retrospective analysis from the IMagyn050 trial
    Journal Article

    You, B.; Anderson, C.; Cecere, S. C.; Carrot, A.; Myers, T.; Heitz, F.; Sharma, S.; Selçukbiricik, F.; Aghajanian, C.; Fernebro, J.; more...
    Gynecologic Oncology (2025)

    Fulltext@MSK | Save
  • Patient outcomes in advanced ovarian cancer treated with an anti-FOLR1 antibody–drug conjugate
    Journal Article

    Johannet, P.; Flint, M.; Chui, M. H.; Konner, J.; Friedman, C.; Green, A. K.; Guo, R.; Hensley, M. L.; Kyi, C.; Liu, Y.; more...
    Gynecologic Oncology (2025)

    Fulltext@MSK | Save
  • Incorporation of triapine (T) to cisplatin chemoradiation (CRT) for locally advanced cervical and vaginal cancer: Results from NRG-GY006, a phase III randomized trial
    Journal Article

    Leath, C. A. 3rd; Deng, W.; Mell, L. K.; Richardson, D. L.; Walker, J. L.; Holman, L. L.; Lea, J. S.; Amarnath, S. R.; Santos-Reyes, L. J.; Arend, R. C.; more...
    Gynecologic Oncology (2025)

    Fulltext@MSK | Save
  • The genomic landscape of distant metastatic endometrial cancer
    Journal Article

    Zammarrelli, W. A. 3rd; Nandakumar, S.; Kertowidjojo, E.; Nguyen, B.; Moukarzel, L. A.; Da Cruz Paula, A.; Rios-Doria, E. V.; Smith, S. A.; Momeni-Boroujeni, A.; Makker, V.; more...
    Gynecologic Oncology (2025)

    Fulltext@MSK | Save
  • A randomized phase II/III study of paclitaxel/carboplatin/metformin versus paclitaxel/carboplatin/placebo as initial therapy for measurable stage III or IVA, stage IVB, or recurrent endometrial cancer: An NRG oncology/GOG study
    Journal Article

    Bae-Jump, V. L.; Sill, M. W.; Gehrig, P. A.; Merker, J. D.; Corcoran, D. L.; Pfefferle, A. D.; Hayward, M. C.; Walker, J. L.; Hagemann, A. R.; Waggoner, S. E.; more...
    Gynecologic Oncology (2025)

    Fulltext@MSK | Save
  • Controversies in the management of mesonephric and mesonephric-like adenocarcinomas of the female genital tract
    Review

    Praiss, A.; Park, K.; Makker, S.; Girshman, J.; Aghajanian, C.; Grisham, R. N.
    International Journal of Gynecological Cancer (2025)

    Fulltext@MSK | Save
  • Basket study of oral progesterone antagonist onapristone extended-release in combination with anastrozole in progesterone receptor-positive recurrent adult-type granulosa cell tumor of the ovary
    Journal Article

    Finch, L.; Andres, S.; Iasonos, A.; Zhou, Q.; Girshman, J.; Chhetri-Long, R.; Green, H.; Selenica, P.; Jang, D.; O'Cearbhaill, R. E.; more...
    International Journal of Gynecological Cancer (2025)

    Fulltext@MSK | Save